Morel, P., Duhamel, A., Hivert, B., Stalnikiewicz, L., Demory, JL & Dupriez, B.(2010)
Identification during the follow-up of timedependent prognostic factors for the competing …

The value of pretransplant splenectomy in patients with myelofibrosis (MF) is subject to
debate, since the procedure may preclude subsequent allogeneic hematopoietic cell …

The role of spleen size and splenectomy for the prediction of post‐allogeneic hematopoietic
stem cell transplant (allo‐HCT) outcome in myelofibrosis remains under debate. In EBMT …

Performing a pretransplantation splenectomy in patients with myelofibrosis (MF) is a matter
of debate, as while the procedure improves hematological recovery, it may lead to severe …

Summary Allogeneic Haematopoietic Stem Cell Transplant (allo‐HSCT) remains the only
curative approach for Myelofibrosis (MF). Scarce information exists in the literature on the …

Splenomegaly is a hallmark of myelofibrosis, a debilitating haematological malignancy for
which the only curative option is allogeneic haematopoietic cell transplantation (HCT) …

The aim of this work is to produce recommendations on the management of allogeneic stem
cell transplantation (allo-SCT) in primary myelofibrosis (PMF). A comprehensive systematic …

Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by
allogeneic hematopoietic stem cell transplantation and is associated with substantial …

Primary or post-ET/PV myelofibrosis is one of the Philadelphia-negative myeloproliferative
neoplasms with worst survival. Allogeneic stem cell transplantation (ASCT) can cure a …

Allogeneic haematopoietic stem‐cell transplantation (HSCT) is the only curative treatment
for myelofibrosis. We report an analysis of the Société Française de Greffe de Moelle et de …